Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-7339
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study ; volume:23 ; number:9 ; day:17 ; month:6 ; year:2015 ; pages:2833-2840 ; date:9.2015
Supportive care in cancer ; 23, Heft 9 (17.6.2015), 2833-2840, 9.2015
- Creator
-
Escobar, Yolanda
Cajaraville, Gerardo
Virizuela, Juan Antonio
Álvarez, Rosa
Muñoz, Andrés
Olariaga, Olatz
Tamés, María José
Muros, Begoña
Lecumberri, María Jose
Feliu, Jaime
Martínez, Purificación
Adansa, Juan Carlos
Martínez, María José
López, Rafael
Blasco, Ana
Gascón, Pere
Calvo, Virginia
Luna, Pablo
Montalar, Joaquín
Barrio, Patricia Del
Tornamira, María Victoria
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-015-2809-3
- URN
-
urn:nbn:de:101:1-2019112021393007369349
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Escobar, Yolanda
- Cajaraville, Gerardo
- Virizuela, Juan Antonio
- Álvarez, Rosa
- Muñoz, Andrés
- Olariaga, Olatz
- Tamés, María José
- Muros, Begoña
- Lecumberri, María Jose
- Feliu, Jaime
- Martínez, Purificación
- Adansa, Juan Carlos
- Martínez, María José
- López, Rafael
- Blasco, Ana
- Gascón, Pere
- Calvo, Virginia
- Luna, Pablo
- Montalar, Joaquín
- Barrio, Patricia Del
- Tornamira, María Victoria
- SpringerLink (Online service)
Other Objects (12)
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Open-label observational study to assess the efficacy and safety of aprepitant for chemotherapy-induced nausea and vomiting prophylaxis in Indian patients receiving chemotherapy with highly emetogenic chemotherapy/moderately emetogenic chemotherapy regimens
Efficacy of oral palonosetron compared to intravenous palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: a phase 3 trial
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study
Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—introduction
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Open-label observational study to assess the efficacy and safety of aprepitant for chemotherapy-induced nausea and vomiting prophylaxis in Indian patients receiving chemotherapy with highly emetogenic chemotherapy/moderately emetogenic chemotherapy regimens
Efficacy of oral palonosetron compared to intravenous palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: a phase 3 trial
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study
Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—introduction
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Open-label observational study to assess the efficacy and safety of aprepitant for chemotherapy-induced nausea and vomiting prophylaxis in Indian patients receiving chemotherapy with highly emetogenic chemotherapy/moderately emetogenic chemotherapy regimens
Efficacy of oral palonosetron compared to intravenous palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: a phase 3 trial
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study